[1]
A. O. Ada, “Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer”, Arh Hig Rada Toksikol, vol. 67, no. 4, Dec. 2016, doi: 10.1515/aiht-2016-67-2812.